Baruch Ben Dor

Chief Executive Officer & Board Member

Dr. Ben Dor holds a Ph.D. in physics. His experience in the electro optics field dates to 1988, in both the defense sector and in the medical device industry. Dr. Ben Dor was previously the general manager of a startup company (Medibell Medical Vision Technologies) in the field of ophthalmic digital photography leading it through finishing of prototype R&D, beta testing, production setup, and sales and marketing network development.

Prior to Medibell Dr. Ben Dor served as the director of marketing in Medibell’s mother company, CMT Medical (OEM producer of digital X-ray for Toshiba Medical). Dr. Ben Dor gained his international marketing experience as the vascular program director in the marketing department of ESC/Sharplan, a global leader in the field of medical lasers, responsible for a worldwide network of reference sites for sales support, conducting clinical studies, and producing successful marketing campaigns.

Nancy Jean Barnabei

Chief Financial Officer

Ms. Barnabei has over 22 years of finance and accounting experience with both public and private companies in the biotechnology industry. She has served in senior financial positions with several emerging companies in which she played a key role in fundraising and the transition to executing growth strategies. Most recently, Ms. Barnabei served as VP Finance for GenSpera, Inc., where she was responsible for financial and administrative matters, SEC reporting, and fundraising activities.

Previously, Ms. Barnabei served as Chief Financial Officer of Immune Control, Inc. and its successor company, Corridor Pharmaceuticals, Inc., a drug development company. She founded Talkeetna Advisors, LLC in 2005, a consulting and advisory firm specializing in biotechnology companies, where she provided guidance on a variety of matters including strategic planning, budgeting, accounting, cash flow management, equity compensation, employee benefits, and raising of capital. From 2000 − 2004, she was Vice President Finance, Treasurer and Chief Financial Officer at Locus Pharmaceuticals, Inc. Her previous experience includes eight years at Cephalon, Inc., concluding as Corporate Controller. Ms. Barnabei earned a BS in business administration from Northeastern University, Boston, and is a certified public accountant.

Yosef Ben Dor

Vice President of International Sales

Mr. Ben Dor holds an MBA from INSEAD, and has extensive international experience. He speaks 5 languages and has lived and worked in Asia and Europe for many years. Mr. Ben Dor has a proven record in sales and distribution channel management and significant understanding and experience in building strategic relations with large multinational firms. In his recent position as the director of sales in Russia for Kodak Graphic Arts he grew annual sales from €12M to €60M within 3 years.

David L. Solt

Vice President for Research and Development

Mr. Solt is an electrical engineer who has specialized in electronic equipment development since 1976. His primary area of expertise has been in medical electronic devices development with the balance in military and commercial communications.

Prior to joining InfraScan, Inc., Mr. Solt was the VP of Manufacturing and R&D with Valley Forge Scientific Corp., directing the research team and leading the manufacturing team. Before that, Mr. Solt founded Omnitronix, a solid state AM broadcast transmitter manufacturer. Mr. Solt holds a Master’s Degree in Business Administration and a Master’s Degree in Engineering.

Roy Bachrach

Vice President of Business Development USA

Mr. Bachrach holds a Master’s degree in Health Administration and a Bachelor’s degree in EMS. He worked for PerSys Medical and served as the company’s Director of Sales and Operations focusing on Military and EMS.  He has been working with distributors and clinical sales managers to promote the right usage of devices. Prior to that, Mr. Bachrach Served as a senior paramedic for over 10 years, and was also a senior instructor both in the civilian and military markets. He served as a paratrooper where he gained  experience in treatment of military injuries and combat casualty care.


Arie Cohen

Executive Chair of the Board

Mr. Cohen has over thirty years of experience as a senior executive in the medical technology industry, compiling a successful track record in growing young companies and corporate operating divisions. Mr. Cohen has been an Operating Executive with SFW Capital Partners, a private equity firm, since 2009.

Previously, he was the President and Chief Executive Officer at CardioNet, a leading wireless medical technology company focused on remote diagnosis and monitoring of cardiac arrhythmias. Mr. Cohen led CardioNet to a successful IPO and secondary offering in 2008. Before joining CardioNet, Mr. Cohen was the Group President at Viasys Healthcare. He led the $450 million Respiratory Care Group overseeing 1200 employees in various locations around the globe. Viasys Healthcare was acquired in 2007 by Cardinal Health for $1.5 billion. Previously, he held executive positions with Respironics, Datascope, and Air-Shields. Mr. Cohen holds a B.S. in Electrical Engineering and an M.S. in Biomedical Engineering from the University of California, Los Angeles.

Prof. Banu Onaral

Board Member

Dr. Onaral is H. H. Sun Professor of Biomedical Engineering and Electrical Engineering at Drexel University. She holds a Ph.D. in Biomedical Engineering from the University of Pennsylvania and BSEE and MSEE in Electrical Engineering from Bogazici University, Istanbul, Turkey. Dr. Onaral joined the faculty of the Electrical and Computer Engineering Department and the Biomedical Engineering and Science Institute in 1981. She has served as the founding Director of the School of Biomedical Engineering Science and Health Systems since 1997. Dr. Onaral’s academic focus in both research and teaching is centered on signals and systems engineering with special emphasis on biomedical signal processing.

She has led major research and development projects sponsored by the National Science Foundation (NSF), National Institutes of Health (NIH), Office of Naval Research (ONR), DARPA, and Department of Homeland Security (DHS). She supervised many graduate students and has an extensive publication record in biomedical signals and systems. She is the recipient of a number of faculty excellence awards including the 1990 Lindback Distinguished Teaching Award of Drexel University, the EDUCOM Best Educational Software award and the NSF Faculty Achievement Award. Dr. Onaral’s professional services include chair and membership on advisory boards and strategic planning bodies of several universities and funding agencies, including service on the National Science Foundation’s Engineering Advisory Board, and on the proposal review panels and study sections.

Her editorial responsibilities have included service on the editorial board of journals and the CRC Biomedical Engineering Handbook as Section Editor for Biomedical Signal Analysis. She served as the President of the IEEE Engineering in Medicine and Biology Society (EMBS), the largest member-based biomedical engineering society in the world. Earlier, she had organized and chaired the 1990 Annual International Conference of the EMBS and served as the Co-Chair of the 2004 Annual Conference of the Biomedical Engineering Society. She has been a member of the inaugural Board of the American Institute for Medical and Biological Engineering. She is a Founding Fellow of the American Institute for Medical and Biological Engineering and a Fellow of the IEEE and the AAAS.

Peter Chance

Board Member

Mr. Chance is President of Non-Invasive Technology, Inc., a private company that licenses fundamental patents to the diagnostic, non-invasive medical device area. Previously, using his background in artificial intelligence, he began work at Unimation, at the time the nation’s largest and oldest industrial robot manufacturer. Mr. Chance left Unimation with Mr. Weiss, an MIT graduate, to start their own robot manufacturing company, U.S. Robots. After producing its first and second generation assembly robots, the Maker 100 and 200 series, they sold the company to Square D Company, an electrical equipment manufacturer.

Mr. Chance is a proponent of technology, innovation, and change, with a particular interest in the potential of artificial intelligence on the future. Mr. Chance belongs to a five-generation University of Pennsylvania family – he is the son of Dr. Britton Chance, an internationally known scholar and Professor Emeritus in Biochemistry/Biophysics, and nephew of Henry Chance II, a Penn Trustee and President of United Engineers, a family business founded by his grandfather, Edwin M. Chance, himself a graduate in civil engineering at Penn.

Shahram Hejazi

Board Member

Dr. Shahram Hejazi is a life science investor/entrepreneur with executive general management experience in early-stage ventures and large global companies. Over his 20+ year career, Shahram has founded and/or directed the growth of more than a dozen startup companies. Since 2009, he has been a Venture Partner with BioAdvance, where he leads investments in devices, diagnostics, research tools and health IT. At BioAdvance he is a Board Director of Infrascan Inc., Optofluidics Inc., Enzium Inc., WellTrackOne Inc., HealthQX LLC (Observer), and Leversense LLC. In addition to his Board responsibilities at BioAdvance, Shahram is also on the Boards of SibTech Inc., and Integral Molecular Inc. Shahram is currently the 2014/2015 James Wei Visiting Professor of Entrepreneurship at Princeton University, teaching a senior/graduate level course on entrepreneurship and venture capital.

Prior to these, (2004-2008), Shahram was the President of Kodak’s Molecular Imaging division – where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service of three diverse business lines – and eventually selling it to a private equity firm. Before Kodak, (2001-2004) he was the founding CEO of Zargis Medical Corp. (a Siemens spinoff ) where he led the company from raising capital and the technology development to completion of several clinical trials, successful FDA regulatory approval and product launch – the company was later sold to 3M. Prior to Zargis, (1996-2001) Shahram was the Global Head of the Strategic Business Development at Siemens medical, responsible for identifying early stage growth/investment opportunities and new business development.

Earlier in his career, Shahram held R&D management positions at Kodak (Rochester) and IBM (Yorktown Heights). His past Board responsibilities includes FDA Industry Advisory Panel Member for Molecular and Clinical Genetic Devices, Fox Chase Cancer Center, Bioscan Inc., Alpha Innotech Corp. Shahram also serves on several university venture panels, and a speaker at many entrepreneurship events. Shahram has a PhD in electrical engineering with emphasis in biophysics (SUNY at Buffalo) and an executive business education (Stanford University).